Abstract：Objective To learn the interaction of serum direct bilirubin and blood lipids on the risk of carotid atherosclerosis and carotid plaque. Methods The subjects were selected from Hangzhou Wuyunshan Sanatorium from March 2016 to December 2018. Demographic information,laboratory testing results and carotid intima-media thickness（IMT）were collected. The logistic regression model was employed for the association of direct bilirubin,blood lipids and their interaction with the risk of carotid atherosclerosis and carotid plaque. Results Totally 8 308 subjects were recruited. Among them,616（7.41%） subjects had carotid atherosclerosis,and 2 409（29.00%）subjects had plaques. The results of multivariate and multinomial logistic regression analysis showed that high level of direct bilirubin was associated with decreased risks of carotid atherosclerosis（OR=0.701,95%CI：0.537-0.916）and carotid plaque（OR=0.647,95%CI：0.527-0.795）;high TC level（OR=1.335,95% CI：1.106-1.611）, high LDL-C level（OR=1.338,95%CI：1.098-1.629）and low HDL-C level（OR=1.431,95%CI：1.148-1.783）were associated with increased risks of carotid atherosclerosis;high TC level（OR=1.325,95% CI：1.151-1.525）and high LDL-C（OR=1.311,95%CI：1.130-1.520）were associated with increased risks of carotid plaque. There were interactions between direct bilirubin and TC or LDL-C on the risk of carotid plaque（P<0.05）. Compared with the subjects with high level of direct bilirubin and normal level of TC,the subjects with normal level of direct bilirubin and high level of TC had significantly higher risk of carotid plaque（OR=1.831,95%CI：1.438-2.333）;compared with the subjects with high level of direct bilirubin and normal level of LDL-C,the subjects with normal level of direct bilirubin and high level of LDL-C had significantly higher risk of carotid plaque（OR=1.814,95%CI：1.427-2.306）.Conclusion The interactions between direct bilirubin and TC or LDL-C increase the risk of carotid plaque. It is important to strengthen blood lipid control in the patients with normal level of direct bilirubin and hyperlipidemia.
范为群, 罗文良, 邵布勒, 余运贤. 直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用[J]. 预防医学, 2020, 32(6): 563-568.
FAN Weiqun, LUO Wenliang, SHAO Bule, YU Yunxian. The interaction between direct bilirubin and blood lipids on carotid atherosclerosis and carotid plaque. Preventive Medicine, 2020, 32(6): 563-568.
 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.  金超,曹中朝.动脉粥样硬化相关因素研究进展[J].现代临床医学,2016,42(3):166-169.  张斯斯,吴金凤,孟晓萍.颈动脉粥样硬化的重新认识[J].中国临床医生杂志,2015,43(2):18-21.  李辉,段东辉,王永,等.宁波市居民血脂异常及影响因素分析[J]. 预防医学,2019,31(5):474-478.  ERDOGAN D,GULLU H,YILDIRIM E,et al.Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women[J]. Atherosclerosis,2006,184(2):431-437.  KWO P Y,COHEN S M,LIM J K.ACG clinical guideline:evaluation of abnormal liver chemistries[J].Am J Gastroenterol, 2017,112(1):18-35.  诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.  SIDHU P S,DESAI S R.A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery[J]. Br J Radiol, 1997,70:85-89.  MA H,LIN H,HU Y,et al.Relationship between non-high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults[J].Lipids Health Dis,2017,16(1):5.  THURSTON R C,CHANG Y,VON KÄNEL R,et al.Sleep character ristics and carotid atherosclerosis among midlife women[J/OL].Sleep,2017(2017-01-01)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084762/.DOI:10.1093/sleep/zsw052.  BARTON M.Cholesterol and atherosclerosis:modulation by oestrogen[J].Curr Opin Lipidol,2013,24(3):214-220.  FERENCE B A,GINSBERG H N,GRAHAM I,et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease.1.Evidence from genetic,epidemiologic,and clinical studies.A consensus statement from the European Atherosclerosis Society Consensus Panel[J].Eur Heart J,2017,38(32):2459-2472.  KAWAMOTO R,NINOMIYA D,HASEGAWA Y,et al.Mildly elevated serum bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons[J/OL].PLoS One,2014(2014-12-05)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4257609/.DOI:10.1371/journal.pone.0114281.  WEN J,HUANG Y,LU Y,et al.Associations of non-high-density lipoprotein cholesterol,triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population[J].Hypertens Res,2019,42(8):1223-1230.  YU X H,ZHANG D W,ZHENG X L,et al.Cholesterol transport system:an integrated cholesterol transport model involved in atherosclerosis[J].Prog Lipid Res,2019,73:65-91.  胡如英,王勇,陈凯伦,等.浙江省农村2型糖尿病患者血脂水平及控制现状[J].预防医学,2019,31(11):1091-1096.  SANDESARA P B,VIRANI S S,FAZIO S,et al.The forgotten lipids: triglycerides,remnant cholesterol,and atherosclerotic cardiovascular disease risk[J].Endocr Rev,2019,40(2):537-557.  VOGEL M E,IDELMAN G,KONANIAH E S,et al.Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling[J]. J Am Heart Assoc, 2017(2017-04-01)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2836 5565/.DOI:10.1161/JAHA.116.004820.  TAKAHASHI S.Triglyceride rich lipoprotein-LPL-VLDL receptor and Lp(a)-VLDL receptor pathways for macrophage foam cell formation[J].J Atheroscler Thromb,2017,24(6):552-559.  MARUHASHI T,KIHARA Y,HIGASHI Y.Bilirubin and endothelial function[J]. J Atheroscler Thromb,2019,26(8): 688-696.  BULMER A C,VERKADE H J,WAGNER K H.Bilirubin and beyond:a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection[J].Prog Lipid Res,2013,52(2):193-205.